by Madeline MS | Nov 28, 2018
Little Dog client ViaCyte made headlines this month with the announcement they have secured $80 million to support their development of stem cell-derived cell replacement therapies, with a focus on the treatment of insulin-requiring diabetes. Together with the... by Madeline MS | Oct 12, 2018
Little Dog client and digital pathology startup Deep Lens, Inc., has exited stealth mode with $3.2 million in seed funding and the launch of the company’s Virtual Imaging for Pathology Education and Research (VIPER) technology to pathologists around the world. Deep... by Madeline MS | Aug 23, 2018
Molecular Assemblies announced the successful completion of an end-to-end run to store and retrieve digital information in DNA. “To our knowledge, we are the first industry group to store and retrieve digital information in DNA using enzymatic synthesis, a... by Madeline MS | Jul 23, 2018
Korea-based Peptron published data showing positive results from preclinical tests of their sustained-release version of exenatide—a peptide that can cross the blood brain barrier and potentially protect the brain in Parkinson’s disease. “The peer-review and... by Madeline MS | Jul 10, 2018
It’s a big week for biotech in Utah! Salt-Lake City-based Recursion announced that the FDA approved the company’s Investigational New Drug application to start a Phase 1 study of REC-994 in cerebral cavernous malformation, a genetic disease that affects up to 1.5... 